Key result
Among women with polycystic ovary syndrome, the overall prevalence of metabolic syndrome was 38.4%, ranging from 0% in those with normal body mass index to 85.5% in morbidly obese women.
Why the study?
What is the prevalence and what are the predictors of metabolic syndrome in women with polycystic ovary syndrome?
Observational (n=73)
What is the prevalence and what are the predictors of metabolic syndrome in women with polycystic ovary syndrome?
Metabolic syndrome is highly prevalent in women with polycystic ovary syndrome, particularly in those who are obese, and is strongly predicted by waist circumference, low HDL-C, and high triglycerides.
No takes yet. Share an insight, caveat, or question.
May warrant MetS screening in obese PCOS women; supports BMI-stratified risk assessment but leaves causal links open.
Marcondes et al. (2007) conducted an observational in Polycystic ovary syndrome (n=73). Higher body mass index vs. Normal body mass index was evaluated on Prevalence of metabolic syndrome. Among women with polycystic ovary syndrome, the overall prevalence of metabolic syndrome was 38.4%, ranging from 0% in those with normal body mass index to 85.5% in morbidly obese women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: